In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Exelon's current price exceeds its fair value by 6.2%, indicating slight overvaluation against a fair value of $43.40. Monte Carlo analysis reveals high volatility with significant downside risk (41.7%) and a broad value range ($24.36 to $1,610.51) reflecting uncertainty in growth and WACC assumptions. Financial health scores suggest modest profitability amid weak growth and efficiency, elevating investment risk.